2024-10-07 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna Group is a global health services company that provides health insurance, pharmacy benefits, and other health-related products and services. 

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:** Cigna (CI) has returned **150.02%**, outperforming the S&P 500 (VOO) with a return of **133.14%.** This indicates a positive relative performance.
* **Performance Gap:** The current difference in cumulative return between Cigna and the S&P 500 is **16.88%**, which is at the **44.52%** percentile of historical data.

**2. Recent Price Movements:**

* **Closing Price:** $341.7
* **5-Day Moving Average:** $343.5
* **20-Day Moving Average:** $353.01
* **60-Day Moving Average:** $346.52

The recent price action suggests a short-term downtrend as the closing price is below all moving averages, indicating a potential sell-off in the short term.

**3. Technical Indicators:**

* **RSI:** 20.65 (Oversold)
* **PPO:** -0.61 (Sell Signal)
* **Delta_Previous_Relative_Divergence:** -15.35 (Short-term Downtrend)
* **Expected_Return:** 7.62% (5-year expected return exceeding S&P 500)

The RSI is currently in the oversold territory, indicating a potential rebound. However, the PPO is negative, signaling a sell signal. The negative Delta_Previous_Relative_Divergence also supports the short-term downtrend observation. Despite the short-term downtrend, the expected return remains positive, suggesting potential long-term growth.

**4. Recent Earnings and Outlook:**

| Date        | EPS     | Revenue        |
|-------------|---------|-----------------|
| 2024-08-01 | 5.51    | $60.52 Billion |
| 2024-05-02 | -0.97   | $57.26 Billion |
| 2023-11-02 | 4.79    | $49.05 Billion |
| 2023-08-03 | 4.96    | $48.59 Billion |
| 2024-08-01 | 4.96    | $48.59 Billion |

Cigna's recent earnings have been mixed, with a strong performance in the latest quarter. While the previous quarter was weak, the company is expected to continue its growth trajectory, especially considering its robust market position and expanding services. 

**5. News and Recent Issues:**

* **Market Outlook:** Cigna's stock performance has been driven by factors such as rising healthcare costs, the growing demand for health insurance, and the company's strategic acquisitions. The company is also benefiting from the overall growth of the health insurance industry. 
* **Analyst Opinions:** Analysts generally maintain a **"Buy"** or **"Hold"** rating for Cigna, citing its strong financial performance and long-term growth prospects.
* **Performance Highlights:** Cigna continues to invest in digitalization and expand its healthcare services, offering a broad portfolio of solutions. The company has recently highlighted its commitment to providing personalized healthcare and improving patient outcomes.

**6. Comprehensive Analysis:**

Cigna Group (CI) has demonstrated a strong track record of outperforming the S&P 500. While recent price action indicates a short-term downtrend, the company's strong financial performance, positive growth prospects, and favorable industry outlook suggest long-term potential.  The technical indicators, including the oversold RSI and negative PPO, require close monitoring, but the positive expected return and analyst sentiment remain encouraging. Overall, Cigna's current performance and long-term potential position it as a strong investment option, especially for investors seeking long-term growth opportunities in the healthcare sector.

**Disclaimer:** This is a simplified analysis and does not constitute financial advice. It is essential to conduct thorough research and consult with a qualified financial professional before making any investment decisions.